Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Montpellier-based biopharmaceutical company continues its rebound in a slightly declining Paris market. The stock ranks among the strongest gainer…
The Montpellier-based biopharmaceutical company posts the strongest gain in its index, in a well-oriented Paris market. The rebound occurs just days a…
The Montpellier-based biopharmaceutical company rebounds during the session, in a Paris market oriented downward. The stock stands out from the SBF 12…
The Montpellier-based biopharmaceutical company is losing ground in early afternoon trading, while the SBF 120 advances. The stock is among the most l…
The Montpellier-based biopharmaceutical company is facing significant selling pressure this Thursday, October 1st, while the SBF 120 itself is losing …
After last Friday's decline, Medincell regains momentum this Monday, in a quasi-stable SBF 120. The share benefits from an improving technical context…
The Montpellier-based biopharmaceutical company is losing momentum this Friday, retreating three days after a notable rebound that had propelled it am…
The Montpellier-based biopharmaceutical company is posting a marked recovery on Tuesday, in a calm Paris market context. The rebound occurs as the sto…
Teva, Medincell's partner, presented new clinical and real-world data on two treatments based on the BEPO technology of the Montpellier-based biopharm…
The Montpellier-based biopharmaceutical company is regaining ground at the close of trading on Thursday, September 17, 2026, advancing in a Paris mark…
